文献速递针灸推拿中医内科

针刺治疗无先兆偏头痛的系统综述与荟萃分析

Acupuncture for migraine without aura: a systematic review and meta-analysis.
PubMed 文献 · J Integr Med · 2018-06-28

该系统综述与荟萃分析纳入14项随机对照试验共1155例无先兆偏头痛患者,比较针刺与口服药物或假针刺的疗效与安全性。结果显示针刺在减少头痛频率、VAS评分和有效率上优于药物,且副作用更少,但纳入研究证据质量多为低至极低,疗效仍不确定。

要点

  • 针刺较药物可减少偏头痛发作频率并提高有效率。
  • 针刺较假针刺可降低头痛频率和VAS评分。
  • 针刺副作用报告少于药物,但证据质量低。

核心结论

  • 针刺治疗无先兆偏头痛的有效性仍不确定,但可能相对药物更安全。
  • 需要进一步证据支持。

研究设计与样本

  • 系统综述与荟萃分析,检索9个电子数据库至2017年6月。
  • 纳入14项随机对照试验,共1155例无先兆偏头痛患者。

主要发现

  • 针刺较药物减少头痛频率(MD=-1.50,95%CI:-2.32至-0.68,P<0.001)。
  • 针刺较药物降低VAS评分(MD=0.97,95%CI:0.63-1.31,P<0.00001)。
  • 针刺较药物提高有效率(RR=1.30,95%CI:1.16-1.45,P<0.00001)。
  • 针刺较假针刺减少头痛频率(MD=-1.05,95%CI:-1.75至-0.34,P=0.004)。
  • 针刺较假针刺降低VAS评分(MD=-1.19,95%CI:-1.75至-0.63,P<0.0001)。

关键数值与推荐

  • 纳入标准为临床诊断无先兆偏头痛的随机对照试验,针刺对照口服药物或假针刺。
  • 主要结局为头痛频率和头痛天数,次要结局包括VAS评分、有效率和不良事件。

临床怎么用

  • 针刺可考虑用于无先兆偏头痛的治疗与预防,尤其关注减少发作频率和疼痛程度。
  • 针刺可能比药物耐受性更好,但需向患者说明证据质量较低。

局限性

  • 纳入研究的证据质量主要为低至极低,对头痛频率和VAS评分结果的信心低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Migraine without aura (MWoA), the most common type of migraine, has great impacts on quality of life for migraineurs. Acupuncture is used in the treatment and prevention of migraine for its analgesic effects. OBJECTIVE: The aim of this systematic review and meta-analysis is to systematically assess the therapeutic and preventive effect of acupuncture treatment and its safety for MWoA. SEARCH STRATEGY: Nine electronic databases (PubMed, MEDLINE, Cochrane Library, Lilacs, Embase, China National Knowledge Infrastructure (CNKI), Chongqing VIP (CQVIP), Wanfang Data and Chinese Clinical Trial Registry (ChiCTR)) were systematically searched from their beginning through June 2017 using MeSH terms such as "acupuncture, acupuncture therapy, electro-acupuncture, ear acupuncture, acupuncture points, acupuncture analgesia," and "migraine disorders, cluster headache." Manual searching included other conference abstracts and reference lists. INCLUSION CRITERIA: Randomized controlled trials (RCTs) with a clinical diagnosis of MWoA, which were treated with acupuncture versus oral medication or sham acupuncture treatment. DATA EXTRACTION AND ANALYSIS: Two evaluators screened and collected literature independently; they extracted information on participants, study design, interventions, follow-up, withdrawal and adverse events and assessed risk of bias and quality of the acupuncture intervention. The primary outcomes were frequency of migraine (FM) and number of migraine days (NM). Secondary outcomes included the visual analogue scale (VAS) score, effective rate (ER) and adverse events. Pooled estimates were calculated as mean difference (MD) with 95% confidence interval (CI) for continuous data and relative risk (RR) with 95% CI for dichotomous data. RESULTS: Overall, 14 RCTs including 1155 participants were identified. The analysis found that acupuncture had a significant advantage over medication in reducing FM (MD = -1.50; 95% CI: -2.32 to -0.68; P < 0.001) and VAS score (MD = 0.97; 95% CI: 0.63-1.31; P < 0.00001) and had a higher ER (RR = 1.30; 95% CI: 1.16-1.45; P < 0.00001). Acupuncture also had a significant advantage over sham acupuncture in the decrease of FM (MD = -1.05; 95% CI: -1.75 to -0.34; P = 0.004) and VAS score (MD = -1.19; 95% CI: -1.75 to -0.63; P < 0.0001). Meanwhile, acupuncture was more tolerated than medication because of less side effect reports (RR = 0.29; 95% CI: 0.17-0.51; P < 0.0001). However, the quality of evidence in the included studies was mainly low (to very low), making confidence in the FM and VAS score results low. CONCLUSION: Our meta-analysis shows that the effectiveness of acupuncture is still uncertain, but it might be relatively safer than medication therapy in the treatment and prophylaxis of MWoA. Further proof is needed.

来源:J Integr Med,查看原文。版权归原作者所有。

引用

  1. Xu J, Zhang FQ, Pei J, et al. Acupuncture for migraine without aura: a systematic review and meta-analysis. J Integr Med. 2018. PMID: 30007828. doi:10.1016/j.joim.2018.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。